Login
$ALDX
$0.67 +$0.03 (4.01%) Live

$ALDX SEC Filings

Filed On Filing
16 Nov 2026 Form 4
13 Nov 2026 Form 4
13 Nov 2026 Form 4: Douglas Richard, Director

Bought 200,000 shares ($129K)

12 Nov 2026 SCHEDULE 13G/A
09 Nov 2026 8-K: Other Events

On November 9, 2026, Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) announced that the Company has formally requested that the Division of Ophthalmology (the “DO”) of the U.S. Food and Drug Administration (the “FDA”) submit a re...

06 Nov 2026 SCHEDULE 13G
05 Nov 2026 10-Q
29 Sep 2026 8-K: Regulation FD Disclosure; Other Events

Aldeyra Therapeutics Announces Intent to Submit Formal Dispute Resolution Request for Reproxalap to Treat Dry Eye Disease

12 Aug 2026 SCHEDULE 13G
06 Aug 2026 10-Q
30 Jul 2026 8-K: Entry into a Material Definitive Agreement

COMMERCIAL LEASE 1 Page PARTIES Bradford Street, LLC, LESSOR, which expression shall include heirs, successors, and assigns where the context so admits, does hereby lease to Aldeyra Therapeutics, Inc., 131 Hartwell Ave, Suite 320, Lexing...

27 Jul 2026 SCHEDULE 13G/A
15 Jul 2026 8-K: Other Events

On July 14, 2026, Aldeyra Therapeutics, Inc. (Aldeyra) received minutes (the Minutes) from a Type A meeting, held on June 10, 2026 with the U.S. Food and Drug Administration (FDA), regarding potential resubmission of the New Drug Applica...

11 Jun 2026 Form 4: Miller-Rich Nancy, Director

Granted 73,318 Stock Option (Right to Buy)

11 Jun 2026 Form 4: Douglas Richard, Director

Granted 92,232 Stock Option (Right to Buy)

11 Jun 2026 Form 4: Phillips Gary M., Director

Granted 81,613 Stock Option (Right to Buy)

11 Jun 2026 Form 4: Clark William D, Director

Granted 72,323 Stock Option (Right to Buy)

11 Jun 2026 Form 4: Walker Neal, Director

Granted 73,318 Stock Option (Right to Buy)

11 Jun 2026 Form 4: Bronstein Ben, Director

Granted 80,286 Stock Option (Right to Buy)

11 Jun 2026 Form 4: Deptula-hicks Darlene M, Director

Granted 94,313 Stock Option (Right to Buy)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support